Literature DB >> 15161726

Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis.

Hans Günther Wahl1, Stephanie Graf, Harald Renz, Winfried Fassbinder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15161726     DOI： 10.1373/clinchem.2003.030692

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  27 in total

Review 1.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

2.  BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.

Authors:  Umair Khalid; Lisa Miller Wruck; Pedro Miguel Quibrera; Biykem Bozkurt; Vijay Nambi; Salim S Virani; Hani Jneid; Sunil Agarwal; Patricia P Chang; Laura Loehr; Sukhdeep Singh Basra; Wayne Rosamond; Christie M Ballantyne; Anita Deswal
Journal:  Int J Cardiol       Date:  2017-01-31       Impact factor: 4.164

3.  Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Jochen D Muehlschlegel; Simon C Body; Stanton K Shernan; Kuang-Yu Liu; Tjorvi E Perry; Sary F Aranki; E Francis Cook; Edward R Marcantonio; Charles D Collard
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

4.  B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients.

Authors:  Choni Rinat; Rachel Becker-Cohen; Amiram Nir; Sofia Feinstein; Nurit Algur; Efrat Ben-Shalom; Benjamin Farber; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2011-10-27       Impact factor: 3.714

5.  Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.

Authors:  Amanda A Fox; Edward R Marcantonio; Charles D Collard; Mathis Thoma; Tjorvi E Perry; Stanton K Shernan; Jochen D Muehlschlegel; Simon C Body
Journal:  Anesthesiology       Date:  2011-04       Impact factor: 7.892

6.  Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Stanton K Shernan; Charles D Collard; Kuang-Yu Liu; Sary F Aranki; Stacia M DeSantis; Petr Jarolim; Simon C Body
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08       Impact factor: 5.209

7.  Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Georg Biesenbach; Erich Pohanka; Tatjana Stojakovic; Jörg Berg
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  Natriuretic peptides in chronic kidney disease.

Authors:  Rajat Tagore; Lieng H Ling; Hong Yang; Hla-Yee Daw; Yiong-Huak Chan; Sunil K Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 8.237

9.  Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.

Authors:  Amanda A Fox; Luigino Nascimben; Simon C Body; Charles D Collard; Aya A Mitani; Kuang-Yu Liu; Jochen D Muehlschlegel; Stanton K Shernan; Edward R Marcantonio
Journal:  Anesthesiology       Date:  2013-08       Impact factor: 7.892

10.  Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).

Authors:  Rakesh K Mishra; Yongmei Li; Ana C Ricardo; Wei Yang; Martin Keane; Magdalena Cuevas; Robert Christenson; Christopher deFilippi; Jing Chen; Jiang He; Radhakrishna R Kallem; Dominic S Raj; Jeffrey R Schelling; Jackson Wright; Alan S Go; Michael G Shlipak
Journal:  Am J Cardiol       Date:  2012-11-22       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.